Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2026)

For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Cellebrite DI was $103.54 million, up 228.0% year-over-year; for the year ended Dec 31, 2025, it was $30.89 million, unchanged from the prior year.

• Annual Other Operating Expenses shows a five-year compound annual growth rate of -12.8% (years ended Dec 2020 to Dec 2025).
• In prior years, Cellebrite DI's Other Operating Expenses was $30.88 million in the year ended Dec 31, 2024 (-0.8%), $31.14 million in the year ended Dec 31, 2023 (-6.6%), $33.32 million in the year ended Dec 31, 2022 (+15.9%) and $28.76 million in the year ended Dec 31, 2021 (-53.1%).
• The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Other Operating Expenses in data going back to the quarter ended Sep 30, 2020.
• On a year-over-year basis, Other Operating Expenses increased in four of the last seven quarters, with growth averaging 2.6%.
• The strongest year-over-year quarter for Other Operating Expenses in the past five years was the quarter ended Mar 31, 2022, with growth of 63.9%; the weakest was the quarter ended Sep 30, 2023, with a decline of 22.6%.
• According to Business Quant data, Other Operating Expenses for the three prior quarters was $6.78 million (quarter ended Mar 31, 2026), $8.76 million (quarter ended Dec 31, 2025) and $7.8 million (quarter ended Sep 30, 2025).